A novel capsid-modified oncolytic recombinant adenovirus type 5 for tumor-targeting gene therapy by intravenous route.

Oncotarget · 2016 · PMC5216942 · PMID 27323824

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

After 6 h, cells infected with rAd5pz-zTRAIL-RFP, but not with rAd5-zTRAIL-RFP, showed an increasing trend towards the late apoptosis stage (upper right quadrant on the plot) (Figure 2F ).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.